Prapela
About:
Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.
Website: https://prapela.com/
Top Investors: U.S. Small Business Administration, National Institutes of Health, Massachusetts Life Sciences Center, National Institute on Drug Abuse (NIDA), Baylor College of Medicine
Description:
Prapela is an affordable, noninvasive stimulation therapy that improves newborn health. Our focus is on three clinical problems experienced by thousands of newborns every day. Placed inside a hospital bassinet or incubator, our reusable pad provides gentle stimulation that helps improve the natural processes of breathing control and oxygenation. Since receiving our first award in 2017, Prapela has become America's most-awarded pediatric medical device startup. With over $8M in grants (and hopefully more), we are honored and motivated to work with neonatologists, the National Institutes of Health, and the FDA to improve the health of newborns.
$8.23M
$1M to $10M
Biddeford, Maine, United States
2017-01-01
info(AT)prapela.com
David Morrill, David Paydarfar, MD, Jim Niemi, John Konsin
1-10
2023-12-19
Private
© 2025 bioDAO.ai